Care of kidney transplant candidates and recipients — case-based management from evaluation to long-term follow-up
This early program on kidney transplant candidates care uses a case-based format to walk through every stage of the transplant journey — from the initial evaluation and listing decision, through wait-list optimization and organ allocation, to perioperative management and long-term recipient follow-up. Faculty address the practical realities of living with a kidney allograft, including immunosuppression selection, over- and under-immunosuppression, graft dysfunction, rejection, and recurrent disease, all within the context of workforce and resource limitations.
-
30video sessions
-
6 h 10 mtotal runtime
-
2025edition
Inside this resource
Evaluation, listing, and barrier removal
Multiple sessions address the front end of the transplant pathway: determining candidacy when chronic kidney disease has multiple causes, navigating cardiac clearance with an evidence-based approach to pretransplant testing, and minimizing barriers for candidates with obesity or socioeconomic challenges. Faculty present strategies to reduce wait-list time and improve access to organs for underserved populations.
Immunosuppression and perioperative management
Dedicated lectures cover choosing the right immunosuppressive regimen for individual recipients, recognizing and treating early and delayed graft dysfunction, and managing outpatient delayed graft function with dialysis. Sessions on pretransplant cardiac testing emphasize a balanced risk approach — knowing when less testing is more.
Post-transplant complications and long-term follow-up
Faculty address identifying and treating rejection episodes, early recurrent disease after kidney transplantation, and monoclonal gammapathies that affect the allograft. A session on setting up for success at discharge ensures continuity between transplant centers and community nephrologists who manage recipients locally.
System-level challenges and emerging frontiers
Programs on regulatory updates, the business of transplantation, and xenotransplantation round out the curriculum. A lecture on SGLT2 inhibitors and GLP-1 receptor agonists after kidney transplantation addresses a fast-evolving area of post-transplant pharmacotherapy. Extended moderated discussions at the end of each block allow real-time audience engagement.
Who this serves
- Transplant nephrologists — updated protocols for evaluation, listing, and post-transplant management
- General nephrologists — practical guidance on co-managing transplant recipients in community practice
- Transplant surgeons and coordinators — perioperative strategies and barrier-minimization approaches
The chart
| Format | Early Program · Videos + PDFs |
|---|---|
| Duration | 6 h 10 m across 30 sessions |
| Publisher | American Society of Nephrology |
| Department | Nephrology |
| Delivery | Instant download after checkout · lifetime re-access |
Verified original fileInstant downloadEncrypted checkout



David K. –
Solid program overall. The xenotransplantation lecture was fascinating and the SGLT2 inhibitor data was timely. Would like a PDF summary of the session list.
Amir P. –
Some sessions felt like introductory material. The graft dysfunction and rejection lectures were excellent, but the earlier sections could go deeper.
Sofia R. –
The moderated discussions were the highlight — real questions from practicing transplant nephrologists. Regulatory and business sessions were a nice addition.
James T. –
Good coverage of immunosuppression selection. Wished for more depth on desensitization protocols for highly sensitized candidates.
Karen M. –
The case-based format made the evaluation-to-transplant pathway much clearer. The session on socioeconomic barriers was especially relevant for our center.
Linda W. –
Exactly what I needed as a community nephrologist co-managing transplant recipients. The discharge planning and local follow-up sessions were directly applicable.